pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

FDA officials stress administration priorities in draft PDUFA VIII commitment letter

Sep 17, 2026·read at raps ↗RegulatoryNeutral

At a public meeting on Wednesday, FDA officials presented the proposed commitment letter for the upcoming PDUFA VIII program.

The letter reiterates the administration's priorities, reflecting the "America First" approach that the agency says will guide the next user‑fee cycle.

The discussion indicates that the FDA intends to align the PDUFA VIII framework with those priorities as it moves toward reauthorization.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Graham: PDUFA VIII reflects ‘America First’ principles”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
CYCLE
topics
PDUFA4

related stories

  • 2d agoRare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meetingBioSpace
  • Sep 2UniQure files for FDA, UK approval of first gene therapy for Huntington’s diseaseBioSpace
  • Aug 13PDUFA VIII: FDA outlines goals, program enhancements in commitment letterraps
  • Jun 15Lilly scores early positive data for new JAK drugBioPharma Dive
  • Jun 13Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73STAT